9 states in the U.S. have legal recreational cannabis and 30 states permit medical cannabis. The State of Florida alone has a medical market of $810M, double the size of the entire Canadian market. The Canada listed marijuana stocks we’ve identified today are great for exposure into the U.S. cannabis market.
The original article has been edited here for length (…) and clarity ([ ]). For the latest – and most informative – financial articles sign up (in the top right corner) for your FREE tri-weekly Market Intelligence Report newsletter (see sample here)
The Canada listed marijuana stocks we’ve identified below are all licensed producers and/or distributors of cannabis in a number of states in the U.S.
1. Cannex Capital Holdings Inc. (CSE:CNNX)
Cannex Group Holdings…[has] cannabis operations in Washington State and California. Cannex is focused on premium indoor cultivation, extraction, manufacturing and branding of edible and derivative products, as well as retail operations. The Company’s subsidiary, BrightLeaf Development LLC, is the largest producer/processor in Washington State. Cannex is also in the process of acquiring Jetty Extracts, one of the largest processors and extractors in California. Cannex plans to produce from two indoor cultivating facilities with a combined 30,000 sq. ft. and 19,000 kg/year capacity, equating to one of the highest yields in the industry at 633 grams/sq. ft.
- Market Cap: C$90.6 Million
- 1 Week Total Return: 4.0%
- 1 Month Total Return: -11.2%
- YTD Total Return: 185.8%
2. MedMen Enterprises Inc. (CSE:MMEN)
MedMen Enterprises is a vertically-integrated cannabis company operating in the U.S. market. The Company has 18 facilities that manufacture and distribute their cannabis product in California, Nevada and New York. On June 6, the Company completed an acquisition of Treadwell Simpson Partnership and its affiliate. Through this transaction MedMen gained Treadwell Nursery’s cultivation facility in Florida and has the license to open 25 additional medical dispensaries in Florida. MedMen is by far the largest cannabis stock listed with operations in the U.S.
- Market Cap: C$2.2 Billion (estimated on 28.8M shares issued and 435.4M in reserves)
- 1 Week Total Return: 31.2%
- 1 Month Total Return: n/m
- YTD Total Return: n/m
3. iAnthus Capital Holdings Inc. (CSE:IAN)
iAnthus Capital Holding operates licensed cannabis facilities and dispensaries throughout the U.S. The Company’s largest production facility is in Florida, totaling 200,000 sq. ft., in addition to operating 30 dispensaries. iAnthus’ 39,500 sq. ft. production facility in New York is expected to be operational by Q2/2019 and the Company currently has four dispensaries in the State. The Company also has operational production facilities in Massachusetts and Vermont of 36,000 sq. ft. and 7,000 sq. ft., respectively.
- Market Cap: C$333.9 Million
- 1 Week Total Return: 22.1%
- 1 Month Total Return: 43.6%
- YTD Total Return: 170.0%
4. Liberty Health Sciences Inc. (CSE:LHS)
Liberty Health Sciences deals with acquisitions of U.S. based medical cannabis companies. The Company is one of 13 licensed producers and sellers of medical cannabis in Florida, and recently has invested in a licensed producer in Massachusetts. The Company’s production facility in Florida is 25,000 sq. ft. and produces 1,600kg of cannabis annually. Liberty Health increased its production by 20% with the assistance it received from Aphria. By November 2018, the Company intends to complete its 200,000 sq. ft. expansion to increase its production capacity to 13,000 kg annually.
- Market Cap: C$295.4 Million
- 1 Week Total Return: 1.1%
- 1 Month Total Return: 3.5%
- YTD Total Return: -57.0%
5. Friday Night Inc. (CSE:TGIF)
Friday Night operates cannabis and hemp-based assets in Las Vegas, Nevada. The Company owns 91% of Alternative Medicine Association, LC, a licensed cultivator, producer and developer of cannabis-based products. The Company also has a 91% stake in Infused MFG, a hemp-based CBD producer. Friday Night has a 12,000 sq. ft. cultivation and production facility and a 5,000 sq. ft. CBD-infused production facility. The Company plans an expansion of 67,000 sq. ft. and has already purchased over five acres of land in Las Vegas for future expansion.
- Market Cap: C$107.4 Million
- 1 Week Total Return: -3.0%
- 1 Month Total Return: -11.9%
- YTD Total Return: -58.6%
Related Articles From the munKNEE Vault:
As recreational legalization in Canada approaches this summer, the 4 marijuana stocks on our list today have plans to meet the upcoming demand. If the marijuana sector continues its rally, these stocks…are expected to generate significant EBITDA growth over the coming year.
To take advantage of another potential upswing in the market, we have selected 5 cannabis companies, which analysts believe are undervalued. The Canadian marijuana stocks on our list today currently have 100% upside on average according to analysts, indicating that these stocks could post strong returns in the near-term.
As recreational legalization of marijuana in Canada approaches this summer, these companies have plans to meet the upcoming demand. If marijuana continues its rally, the Canadian marijuana stocks on our list could see strong returns in both the short and long term.
The top spot in the Canadian cannabis industry belongs to Canopy Growth Corp. but some competitors, such as Aurora Cannabis Inc., have the scope, scale, and differentiation to take on the market leader. Of these two which stock is more attractive?
Today we will be comparing the current and future prospects of Aurora Cannabis and Aphria Inc. – the only two companies with the scope, scale, and differentiation to take on Canopy Growth.
Due to the early stages of the cannabis industry and its growth prospects, investors have not expected cannabis companies to generate positive earnings. Instead they have valued the stocks primarily on hope for a lucrative future. That being said, however, we have identified 4 Canadian cannabis stocks that are expected to generate positive earnings in the next 12 months. If they live up to their earnings expectations, it could begin a time when investors look for companies with sustainable growth prospects, as opposed to those that are expected to have the highest short-term revenue growth.
Like technology, the battery metals and cannabis sectors have upside attached to secular trends that are changing our world. As a result, all of these sectors are poised to continue expanding at rapid rates.
Being able to sell products at a high margin is a good sign of efficiency. Doing so leaves more cash to dedicate to other expenses and service debt obligations. Identifying undervalued companies with strong gross margins in the young marijuana industry is important, given the upcoming Canadian legalization of marijuana for recreational purposes in 2018. Today we have identified 4 Canadian marijuana stocks that have underperformed their peers despite healthy gross margins.
Investing in marijuana-related stocks is a high-risk, high-reward game due to all the uncertainties surrounding the legalization of the drug. Companies that do succeed, however, have potential to bring large capital gains. That being said we have identified five Canadian marijuana stocks with the biggest upside potential, according to consensus analyst price targets.
Identifying companies with high gross margins in the young marijuana industry is important because operating costs are likely to decrease as the industry matures, leaving these companies with high earnings potential. Today we have identified five Canadian marijuana stocks with gross margins well above their industry peers.
The search is now on for the next junior marijuana stock that is ripe for acquisition. Will it be one of the 5 we’ve identified based upon their high revenue growth profiles?
As legalization approaches cannabis companies must compete for supply agreements and retail space…[and those companies best] increasing their production and sales to meet demand could capture a strong retail presence early on. The Canadian cannabis stocks on our list today have released their financial results recently, giving investors insight into their production and revenue increases.
Today we have identified seven Canadian cannabis producers based on sale cost and production efficiency.